| Mon, Jan 4, 2010 | | • | Dynavax wraps up Symphony Dynamo deal
at bizjournals.com (Mon, Jan 4)
| | • | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D
EDGAR Online (Mon, Jan 4)
| | • | Dynavax Completes Symphony Dynamo Acquisition
Marketwire (Mon, Jan 4)
| | Tue, Dec 29, 2009 | | • | Swine Flu Vaccine News Back From the Dead
Indie Research (Tue, Dec 29)
| | Fri, Dec 11, 2009 | | • | Good News for Dynavax
Zacks.com (Fri, Dec 11)
| | Thu, Dec 10, 2009 | | • | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 10)
| | Wed, Dec 9, 2009 | | • | Biotech Stocks: Drug stocks trend lower; Pfizer, Dynavax gain
at MarketWatch (Wed, Dec 9)
| | • | Dynavax gets OK at German factory for hepatitis vaccine work
at bizjournals.com (Wed, Dec 9)
| | • | Dynavax's European Manufacturing Facility Approved for Commercial Production of HEPLISAV Hepatitis B Surface Antigen
Marketwire (Wed, Dec 9)
| | Thu, Nov 19, 2009 | | • | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 19)
| | • | DVAX Completes Hep-B Enrollment
Zacks.com (Thu, Nov 19)
| | • | Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B Therapy
Marketwire (Thu, Nov 19)
| | Tue, Nov 17, 2009 | | • | Big Pullback for Top Swine Flu Small-Caps
Indie Research (Tue, Nov 17)
| | Tue, Nov 10, 2009 | | • | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
EDGAR Online (Tue, Nov 10)
| | • | Dynavax Technologies to buy Symphony Dynamo
at bizjournals.com (Tue, Nov 10)
| | • | Dynavax to buy Symphony Dynamo
at MarketWatch (Tue, Nov 10)
| | • | Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash
Marketwire (Tue, Nov 10)
| | Thu, Nov 5, 2009 | | • | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
EDGAR Online (Thu, Nov 5)
| | • | The $2000 Swine Flu Drug
Indie Research (Thu, Nov 5)
| | • | Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors
Business Wire (Thu, Nov 5)
|
Add DVAX News to My Yahoo!:
 
| |
|
0.11% Nasdaq 0.00%
Headlines
